• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Middle East’s Aster DM Healthcare Announces Partnership with Roche Diagnostics

Share:

June 8, 2021

One of the GCC’s largest integrated healthcare service providers has partnered with Roche Diagnostics to transform its diagnostic solutions across its hospitals, clinics, and laboratories, it has been announced.

This week, Aster DM Healthcare signed a Memorandum of Understanding (MoU) with the Swiss multinational to transform “Aster’s existing systems into a single platform with the latest state-of-art technology, aimed at providing optimal results to patients and their treating physicians,” it said in a statement.

The agreement will reportedly focus on Aster’s entities in the United Arab Emirates (UAE), the Kingdom of Saudi Arabia (KSA), Qatar, and Oman.

“At Aster, we are determined to stay ahead of the curve in offering the best medical solutions to our patients and equip our doctors with the most advanced systems to be able to do so,” said Alisha Moopen, Deputy Managing Director at Aster DM Healthcare. “The partnership with Roche Diagnostics in the Middle East underscores our dedication to supporting countries, patients, and medical fraternity across the region through providing the latest healthcare solutions relating to the prevention, diagnosis, and treatment of various diseases.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“This is a part of our core strategy to introduce smart systems that encourage early and accurate detection that can facilitate timely medical intervention essential to prevent unwanted disease outcomes.”

Aster DM Healthcare currently runs 27 hospitals and 115 clinics in the GCC and India.

WHY IT MATTERS

According to the company, the partnership not only aims to introduce more efficient systems – such as testing for multiple diseases using minimal samples – but also provide automated laboratory solutions to “deliver high-quality and precise patient results in the shortest time possible.”

Hanie Abdul Sathar, a director at healthcare management services provider, Eurohealth Systems (EHS), also an Aster partner, elaborated: “This project marks the start of a transformation journey that would enhance the service offering of Aster Laboratories across GCC… Through system integration and consolidation we are aiming to develop state-of-art infrastructure for diagnostics founded on intelligent systems, sophisticated quality procedures, instrument technology enhancements.

“[It is] all with the purpose of equipping our doctors with the best systems needed to be able to provide the optimal treatment solution to patients.”

ON THE RECORD

“The establishment of this collaboration is a testament to Roche Diagnostics’ dedication towards supporting countries across the Middle East to further elevate their standards of healthcare and bring in the latest innovations to serve patients better,” said Harald Wolf, General Manager at Roche Diagnostics Middle East. “This partnership will further align our commitment to upscale and expand healthcare opportunities and services to all residents across the UAE, KSA, Oman, and Qatar.”

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Paragon Biosciences Adds CiRC Biosciences to Expand Cell and Gene Therapy PlatformParagon Biosciences Adds CiRC Biosciences to Expand Cell and Gene Therapy Platform
  • ACELYRIN, INC. Furthers Leadership Position in Immunology with Transformative Acquisition of ValenzaBioACELYRIN, INC. Furthers Leadership Position in Immunology with Transformative Acquisition of ValenzaBio
  • Sharecare Creates Free Embeddable COVID-19 Chatbot ScreenerSharecare Creates Free Embeddable COVID-19 Chatbot Screener
  • DrChrono Launches EHR Services Directory for Medical PracticesDrChrono Launches EHR Services Directory for Medical Practices
  • Astellas buys gene therapy company QuetheraAstellas buys gene therapy company Quethera
  • Rally Health Launches Next-Gen Consumer Digital Health PlatformRally Health Launches Next-Gen Consumer Digital Health Platform
  • Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation.Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation.
  • Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma PurchaseLilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications